Press Releases

November 23, 2023 Lupin Receives Approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.07%

November 23, 2023 Lupin Receives Tentative Approval from U.S. FDA for Canagliflozin Tablets

November 23, 2023 Lupin Launches World’s First Fixed-dose Triple Combination Drug, Vilfuro-G® for COPD Management in India

November 21, 2023 Lupin Receives Approval from U.S. FDA for Pitavastatin Tablets

November 21, 2023 Lupin Receives Tentative Approval from U.S. FDA for Dapagliflozin Tablets

November 17, 2023 Lupin Receives Approval from U.S.FDA for Ganirelix Acetate Injection

November 10, 2023 Lupin and Amman Pharma Sign Exclusive Licensing and Supply Agreement for Ranibizumab Biosimilar

November 8, 2023 Lupin Q2 FY2024 Results

November 8, 2023 Lupin Launches Rocuronium Bromide Injection in the United States